Teva Pharmaceutical Industries Limited (VIE:TEVA)

Market Cap	33.08B +91.2%
Revenue (ttm)	15.05B +4.4%
Net Income	1.36B
EPS	1.16
Shares Out	n/a
PE Ratio	24.37
Forward PE	14.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	391
Open	28.30
Previous Close	28.40
Day's Range	28.30 - 28.70
52-Week Range	13.25 - 31.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About VIE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 32,008
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD